Prelude Capital Management, LLC Concert Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.48 - $12.84 $15,793 - $21,391	-1,666 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.67 - $10.82 $14,444 - $18,026	1,666 New	1,666 $16,000
Q1 2020 May 15, 2020	SELL	$5.98 - $13.09 $15,452 - $33,824	-2,584 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.71 - $9.22 $5,230 - $8,445	-916 Reduced 26.17%	2,584 $24,000
Q3 2019 Nov 14, 2019	BUY	$5.88 - $12.35 $15,852 - $33,295	2,696 Added 335.32%	3,500 $21,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $13.12 $7,589 - $10,548	804 New	804 $10,000
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $7,998 - $11,496	-711 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$12.82 - $17.88 $12,602 - $17,576	-983 Reduced 58.03%	711 $11,000
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $28,510 - $36,692	1,694 New	1,694 $29,000
Q4 2017 Feb 14, 2018	SELL	$13.96 - $29.05 $9,772 - $20,335	-700 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$13.91 - $15.31 $9,737 - $10,717	700	700 $10,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.